Filing metadata

Accession number
0001140361-23-032216
Form type
Form 4
Filer
Atara Biotherapeutics, Inc.
CIK
CIK 1604464
Filed
Jun 29, 2023
Reporting period
Jun 27, 2023
Description
Insider transaction

Explore SEC Filings Hub